A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2
Author Countries: United States
Funding: This work was supported by WSU and the Paul G. Allen School for Global Health (ML BG, SNS, SF, SB). Funding for the clinical study specimens was provided under NIH Project U54CA260581-01 (JR, KZ, EN) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Method of Research
Subject of Research
Competing Interests: The authors have declared that no competing interests exist.